Rising Covid cases in China may once again trigger a shortage of active pharmaceutical ingredients (APIs) in India, which imports over 65 per cent of APIs from the neighbouring nation.
China targeting India? Import costs of paracetamol, antibiotics ingredients see 100% jump
Experts believe hiking prices could be Chinese response to the Modi government’s Profit Linked Incentive scheme, which seeks to achieve self-dependence in API production.
Himani Chandna 12 March, 2021 9:10 am IST
A+
New Delhi: The prices of raw materials to manufacture medicines have started moving up, yet again. And China is to be blamed.
The prices of raw materials, known as active pharmaceutical ingredients (APIs) or bulk drugs, have grown multifold since November. The same trend was seen in April last year, when several Chinese units and trade corridors shut down due to the Covid outbreak.